3/12
10:59 am
uthr
United Therapeutics (UTHR) had its price target raised by Cantor Fitzgerald from $525.00 to $625.00. They now have an "overweight" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by Cantor Fitzgerald from $525.00 to $625.00. They now have an "overweight" rating on the stock.
3/12
08:42 am
uthr
Asylon Robotics Announces New Advisors, Additions to Leadership Team [Yahoo! Finance]
Low
Report
Asylon Robotics Announces New Advisors, Additions to Leadership Team [Yahoo! Finance]
3/11
07:30 pm
uthr
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine [Yahoo! Finance]
Low
Report
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine [Yahoo! Finance]
3/11
06:14 pm
uthr
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
Low
Report
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
3/11
06:57 am
uthr
United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade) [Seeking Alpha]
Low
Report
United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade) [Seeking Alpha]
3/9
03:30 pm
uthr
United Therapeutics Corporation (UTHR) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
United Therapeutics Corporation (UTHR) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/9
07:16 am
uthr
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program [Yahoo! Finance]
High
Report
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program [Yahoo! Finance]
3/9
07:00 am
uthr
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program
Medium
Report
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program
3/8
08:34 am
uthr
United Therapeutics' Ralinepag Success Adds To Long Term Value Story [Yahoo! Finance]
High
Report
United Therapeutics' Ralinepag Success Adds To Long Term Value Story [Yahoo! Finance]
3/5
10:24 am
uthr
United Therapeutics (UTHR) had its price target raised by UBS Group AG from $655.00 to $705.00. They now have a "buy" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by UBS Group AG from $655.00 to $705.00. They now have a "buy" rating on the stock.
3/3
07:23 am
uthr
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference [Yahoo! Finance]
Low
Report
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference [Yahoo! Finance]
3/3
07:00 am
uthr
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference
Low
Report
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference
3/2
09:02 pm
uthr
United Therapeutics (UTHR) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
United Therapeutics (UTHR) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/2
04:32 pm
uthr
United Therapeutics Corporation (UTHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Low
Report
United Therapeutics Corporation (UTHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/2
04:12 pm
uthr
United Therapeutics Corporation (UTHR) Discusses Phase III ADVANCE OUTCOMES Clinical Trial Results in Pulmonary Hypertension Transcript [Seeking Alpha]
Low
Report
United Therapeutics Corporation (UTHR) Discusses Phase III ADVANCE OUTCOMES Clinical Trial Results in Pulmonary Hypertension Transcript [Seeking Alpha]
3/2
06:53 am
uthr
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy [Yahoo! Finance]
Low
Report
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy [Yahoo! Finance]
3/2
06:30 am
uthr
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy
Medium
Report
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy
3/1
10:23 am
uthr
H.C. Wainwright Raises United Therapeutics (UTHR) Target to $600 [Yahoo! Finance]
Low
Report
H.C. Wainwright Raises United Therapeutics (UTHR) Target to $600 [Yahoo! Finance]
2/28
08:32 pm
uthr
Assessing United Therapeutics (UTHR) Valuation After Strong Earnings And Pipeline Updates [Yahoo! Finance]
Low
Report
Assessing United Therapeutics (UTHR) Valuation After Strong Earnings And Pipeline Updates [Yahoo! Finance]
2/27
09:47 pm
uthr
Stocks Showing Market Leadership: United Therapeutics Earns 91 RS Rating [Yahoo! Finance]
Low
Report
Stocks Showing Market Leadership: United Therapeutics Earns 91 RS Rating [Yahoo! Finance]
2/27
07:12 am
uthr
Liquidia Appears Set For Strong 2026 On Further Share Gains [Seeking Alpha]
Low
Report
Liquidia Appears Set For Strong 2026 On Further Share Gains [Seeking Alpha]
2/26
05:33 pm
uthr
MannKind Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
MannKind Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
02:33 pm
uthr
Why United Therapeutics (UTHR) Shares Are Sliding Today [Yahoo! Finance]
Low
Report
Why United Therapeutics (UTHR) Shares Are Sliding Today [Yahoo! Finance]
2/26
01:58 pm
uthr
United Therapeutics (UTHR) had its price target raised by HC Wainwright from $525.00 to $600.00. They now have a "buy" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by HC Wainwright from $525.00 to $600.00. They now have a "buy" rating on the stock.
2/26
12:26 pm
uthr
United Therapeutics (UTHR) had its price target raised by Oppenheimer Holdings, Inc. from $575.00 to $600.00. They now have an "outperform" rating on the stock.
Low
Report
United Therapeutics (UTHR) had its price target raised by Oppenheimer Holdings, Inc. from $575.00 to $600.00. They now have an "outperform" rating on the stock.